Novartis AG (NOVN)

Basic

  • Market Cap

    CHF 178.39B

  • EV

    CHF 189.78B

  • Shares Out

    2,055.46M

  • Revenue

    $54.22B

  • Employees

    101,703

Margins

  • Gross

    71.27%

  • EBITDA

    39.83%

  • Operating

    29.83%

  • Pre-Tax

    17.54%

  • Net

    14.45%

  • FCF

    26.07%

Returns (5Yr Avg)

  • ROA

    5.22%

  • ROE

    19.58%

  • ROCE

    10.86%

  • ROIC

    8.19%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    CHF 105.07

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $25.84

  • Earnings (Dil)

    $3.72

  • FCF

    $6.69

  • Book Value

    $18.57

Growth (CAGR)

  • Rev 3Yr

    3.02%

  • Rev 5Yr

    2.74%

  • Rev 10Yr

    0.02%

  • Dil EPS 3Yr

    7.8%

  • Dil EPS 5Yr

    -7.71%

  • Dil EPS 10Yr

    0.41%

  • Rev Fwd 2Yr

    -3.32%

  • EBITDA Fwd 2Yr

    1.1%

  • EPS Fwd 2Yr

    6.95%

  • EPS LT Growth Est

    7.94%

Dividends

  • Yield

    —

  • Payout

    89.07%

  • DPS

    $3.46

  • DPS Growth 3Yr

    3.51%

  • DPS Growth 5Yr

    3.31%

  • DPS Growth 10Yr

    3.26%

  • DPS Growth Fwd 2Yr

    2.46%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Revenues

44,833.0

47,498.0

48,659.0

51,626.0

50,545.0

52,932.0

Other Revenues, Total

1,266.0

1,179.0

1,239.0

1,251.0

1,283.0

1,285.0

Total Revenues

46,099.0

48,677.0

49,898.0

52,877.0

51,828.0

54,217.0

Total Revenues % Chg.

6.2%

5.6%

2.5%

6.0%

-2.0%

17.8%

Cost of Goods Sold, Total

14,510.0

14,425.0

15,121.0

15,435.0

15,084.0

15,576.0

Gross Profit

31,589.0

34,252.0

34,777.0

37,442.0

36,744.0

38,641.0

Selling General & Admin Expenses, Total

13,717.0

14,369.0

14,197.0

14,815.0

14,190.0

14,225.0

R&D Expenses

8,489.0

9,402.0

8,980.0

9,150.0

9,246.0

9,026.0

Other Operating Expenses

459.0

1,395.0

1,448.0

653.0

449.0

-784.0

Other Operating Expenses, Total

22,665.0

25,166.0

24,625.0

24,618.0

23,885.0

22,467.0

Operating Income

8,924.0

9,086.0

10,152.0

12,824.0

12,859.0

16,174.0

Interest Expense, Total

-932.0

-850.0

-869.0

-811.0

-837.0

-882.0

Interest And Investment Income

292.0

245.0

91.0

71.0

379.0

379.0

Net Interest Expenses

-640.0

-605.0

-778.0

-740.0

-458.0

-503.0

Income (Loss) On Equity Invest.

6,438.0

659.0

673.0

15,339.0

-9.0

-8.0

Currency Exchange Gains (Loss)

-68.0

-160.0

-135.0

-69.0

-184.0

-184.0

Other Non Operating Income (Expenses)

-38.0

-40.0

-34.0

-43.0

-54.0

149.0

EBT, Excl. Unusual Items

14,616.0

8,940.0

9,878.0

27,311.0

12,154.0

15,628.0

Restructuring Charges

-521.0

—

—

—

—

-3.0

Merger & Related Restructuring Charges

—

—

—

—

—

—

Gain (Loss) On Sale Of Investments

—

—

—

38.0

-260.0

-41.0

Gain (Loss) On Sale Of Assets

—

—

—

728.0

166.0

249.0

Asset Writedown

—

—

—

-653.0

-1,687.0

-4,384.0

Legal Settlements

—

—

—

-212.0

-369.0

84.0

Other Unusual Items

—

—

—

-1,075.0

-1,633.0

-2,024.0

EBT, Incl. Unusual Items

14,095.0

8,940.0

9,878.0

26,137.0

8,371.0

9,509.0

Income Tax Expense

1,295.0

1,793.0

1,807.0

2,119.0

1,416.0

1,354.0

Earnings From Continuing Operations

12,800.0

7,147.0

8,071.0

24,018.0

6,955.0

8,155.0

Earnings Of Discontinued Operations

-186.0

4,590.0

—

—

—

-315.0

Minority Interest

-3.0

-5.0

1.0

3.0

—

-4.0

Net Income

12,611.0

11,732.0

8,072.0

24,021.0

6,955.0

7,836.0

Net Income to Common Incl Extra Items

12,611.0

11,732.0

8,072.0

24,021.0

6,955.0

7,836.0

Net Income to Common Excl. Extra Items

12,797.0

7,142.0

8,072.0

24,021.0

6,955.0

8,151.0

Total Shares Outstanding

2,311.2

2,265.0

2,256.8

2,234.9

2,119.6

2,055.5

Weighted Avg. Shares Outstanding

2,319.3

2,290.8

2,277.0

2,242.6

2,181.2

2,097.9

Weighted Avg. Shares Outstanding Dil

2,344.0

2,319.0

2,296.0

2,260.0

2,197.0

2,113.0

EPS

5.4

5.1

3.5

10.7

3.2

3.7

EPS Diluted

5.4

5.1

3.5

10.6

3.2

3.7

EBITDA

14,135.0

13,267.0

14,932.0

17,935.0

18,004.0

21,593.0